CALM Bullish Call Contradicts Filing Data and Legal Overhangs

What happened

A Seeking Alpha article argues Cal-Maine Foods is undervalued as its recent Creighton Brothers acquisition and ongoing buybacks are not fully priced in. However, DeepValue's report reveals CALM is in a post-spike downcycle, with Q3 FY26 net income plunging to $50.5 million from $508.5 million year-over-year. Critical scrutiny shows the article cites a $128.5M acquisition cost, but SEC filings indicate an approximate $22 million purchase price, raising red flags about promotional accuracy. This acquisition supports specialty egg diversification, yet shell eggs still dominate 85.8% of sales, and legal risks from antitrust MDL consolidation and DOJ investigations loom large. Investors must balance optimistic narratives against filed financials and the report's emphasis on mix sustainability and legal escalation risks.

Implication

The article's undervaluation claim is questionable due to discrepancies in acquisition details and neglect of DeepValue's identified risks. CALM's earnings remain volatile, driven by shell egg pricing, with specialty mix at 50.5% of shell egg dollars providing only partial stability. Prepared foods, though growing, represent less than 10% of sales and have not yet de-commoditized the earnings base. Legal overhangs, including potential MDL discovery and state subpoenas, could cap valuation upside and threaten capital returns. Therefore, investors should adhere to the report's 'WAIT' rating, focusing on quarterly checkpoints for specialty share and legal developments before considering entry.

Thesis delta

The article posits a shift towards undervaluation from unpriced acquisitions, but this does not materially change DeepValue's thesis that CALM is fairly valued amid downcycle pressures and legal uncertainties. Instead, the thesis remains anchored on specialty mix holding near 50% and prepared foods scaling without margin dilution, with legal risks as a key gating factor. Investors should dismiss bullish calls based on inaccurate data and prioritize the report's risk-aware framework until concrete improvements emerge.